Discovery of Novel 5α-Reductase Type II Inhibitors by Pharmacophore Modelling, Virtual Screening, Molecular Docking and Molecular Dynamics Simulations
January 2014
in “
Molecular Simulation
”
Studysummary This study discovered a potential new 5α-reductase type II inhibitor with higher predicted activity than finasteride, suggesting it as a promising candidate for treating benign prostatic hyperplasia.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on tandfonline.com →